Azintuxizumab Biosimilar – Anti-SLAMF7, CRACC, CD319 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameAzintuxizumab Biosimilar - Anti-SLAMF7, CRACC, CD319 mAb - Research Grade
SourceCAS 1826819-57-1
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsAzintuxizumab,ABBV-383,PR-1471272,SLAMF7, CRACC, CD319,anti-SLAMF7, CRACC, CD319
ReferencePX-TA1464
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Azintuxizumab Biosimilar – Anti-SLAMF7, CRACC, CD319 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human CD319 recombinant protein
Antigen

Human CD319 recombinant protein

PX-P5125 110€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products